Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features ofAMLwith mutated nucleophosmin (NPM1)

Brunangelo Falini, Katja Macijewski, Tamara Weiss, Ulrike Bacher, Susanne Schnittger, Wolfgang Kern, Alexander Kohlmann, Hans Ulrich Klein, Marco Vignetti, Alfonso Piciocchi, Paola Fazi, Maria Paola Martelli, Antonella Vitale, Stefano Pileri, Miriam Miesner, Antonella Santucci, Claudia Haferlach, Franco Mandelli, Torsten Haferlach

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features ofAMLwith mutated nucleophosmin (NPM1)'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences